NASDAQ:AEON AEON Biopharma Q4 2023 Earnings Results & Report $0.23 -0.01 (-4.53%) Closing price 10/16/2026 04:00 PM EasternExtended Trading$0.24 +0.00 (+2.16%) As of 10/16/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. AEON Biopharma reported Q4 2023 earnings on March 29, 2024. The company reported EPS of -$51.12. Research:ProfileForecast Earnings Announcement Details QuarterQ4 2023Report DateMarch 29, 2024 AEON Biopharma EPS ResultsActual EPS-$51.12Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAEON Biopharma Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsAEON Biopharma's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules. Conference Call ResourcesCompany Profile AEON Biopharma Q4 2023 Earnings FAQ Did AEON Biopharma beat earnings estimates for Q4 2023? AEON Biopharma (NASDAQ:AEON) reported earnings of -$51.12 per share for Q4 2023. The report was announced on Friday, March 29, 2024. When is AEON Biopharma's next earnings date? AEON Biopharma's next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for AEON Biopharma on the company's earnings history page. AEON Biopharma Earnings HeadlinesCertain Options of AEON Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026.October 12, 2026 | marketscreener.comMZacks Research Forecasts AEON Biopharma Q3 EarningsOctober 10, 2026 | americanbankingnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. | Porter & Company (Ad)AEON Biopharma Reports Inducement Grant Under NYSE American LLC Company Guide Section 711October 9, 2026 | markets.businessinsider.comAEON Biopharma, Inc. (AEON) Stock Major Holders - Yahoo FinanceOctober 7, 2026 | finance.yahoo.comAEON: Initiating Coverage – Imitation is a Sincere Form of Flattery: Seeking a Botox BiosimilarOctober 5, 2026 | finance.yahoo.comSee More AEON Biopharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like AEON Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AEON Biopharma and other key companies, straight to your email. Email Address About AEON BiopharmaAEON Biopharma (NASDAQ:AEON) is a clinical-stage biopharmaceutical company focused on developing therapeutic applications of botulinum toxin. Unlike companies that primarily target aesthetic uses, AEON is developing treatments for neurological and other medical conditions in which botulinum toxin may provide therapeutic benefits. The company’s lead product candidate is ABP-450, an investigational botulinum neurotoxin type A complex licensed from Daewoong Pharmaceutical. AEON has evaluated ABP-450 in clinical programs targeting conditions including chronic migraine and cervical dystonia, and its broader development strategy may encompass additional therapeutic indications. ABP-450 has not received regulatory approval for these uses. AEON Biopharma became a publicly traded company through a business combination with Priveterra Acquisition Corp. in 2023 and is headquartered in Irvine, California. The company’s programs are intended for markets in the United States and other international jurisdictions, subject to clinical results and regulatory approvals. Marc Forth serves as the company’s president and chief executive officer.View AEON Biopharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Bank of America Stock Sell-Off Looks Like a Buying OpportunityMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
